July 22, 2024
A new compound shows promise in overcoming chemotherapy resistance in triple-negative breast cancer -- and could potentially be applied to fibrotic conditions like liver fibrosis or pulmonary fibrosis.
Team marks milestone in progress toward investigational new drug for triple-negative breast cancer
July 22, 2024
A virtual reality training series being developed for medical students and physicians teaches them about implicit bias in their communications with their patients who are people of color and how that affects race-based health care disparities.
Virtual reality training for physicians aims to heal disparities in Black maternal health care
July 19, 2024
The function of brain areas critical to memory performance varies with estrogen levels in the postmenopause, even though those levels are low. Higher levels of estradiol may facilitate memory performance through enhanced function of temporal and frontal cortices during encoding of verbal material.
July 18, 2024
Women are likelier to die from breast and cervical cancer in a cluster of southern states where screenings and other preventive care lag behind the rest of the country.
Women are more likely to die from cancer in the southern U.S
July 18, 2024
Scorecard Highlights: Massachusetts, Vermont, and Rhode Island top the rankings for the 2024 State Scorecard on Women’s Health and Reproductive Care, which is based on 32 measures of health care access, quality, and health outcomes. The lowest performers were Mississippi, Texas, Nevada, and Oklahoma. Deaths from all causes among women of reproductive age — 15 to 44 — were highest in southeastern states. Causes of death include pregnancy and other preventable causes such as substance use, COVID-19, and treatable chronic conditions. The highest maternal death rates were in Tennessee, Mississippi, and Louisiana. Vermont, California, and Connecticut had the lowest rates. Nationally, rates were highest for Black and American Indian and Alaska Native (AIAN) women. Mental health conditions are the most frequently reported cause of preventable pregnancy-related death, including deaths by suicide and overdoses related to substance use disorders. States that screened for postpartum depression at the highest rates also had lowest rates of postpartum depression. Among women of reproductive age (ages 15–44), those in Texas, Georgia, and Oklahoma were uninsured at the highest rates; those in Massachusetts, the District of Columbia, and Vermont had the lowest uninsured rates. Women in states that had not expanded Medicaid eligibility were among those most at risk of lacking coverage. The U.S. Supreme Court decision overturning Roe v. Wade in June 2022 has significantly altered both access to reproductive health care services and how providers are able to treat pregnancy complications in the 21 states that ban or restrict abortion access.
2024 State Scorecard on Women’s Health and Reproductive Care
July 16, 2024
A new study finds that early detection of specific microRNAs (miRNAs) packaged in vesicles may offer the opportunity to predict preeclampsia in pregnant people before clinical symptoms manifest.
July 16, 2024
Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study.
Hormone therapy for breast cancer linked with lower dementia risk
July 11, 2024
About 40% of new cancer cases among adults ages 30 and older in the United States — and nearly half of deaths — could be attributed to preventable risk factors, according to a new study from the American Cancer Society.
July 11, 2024
A new study finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.
July 10, 2024
Researchers have created an eco-friendly, blood absorbent biomaterial that improves the performance of menstrual products by minimizing blood leakage and spilling, while also helping prevent infection.
